NCI SBIR provides
funding, mentoring & networking assistance
for small businesses with next-generation cancer technologies.
The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.
Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.
Their MxStructure™ software uses auto-segmentation to better focus radiation treatment and minimize exposure to surrounding healthy tissue. They were acquired by Accuray in 2012.
AntiCancer, the San Diego-based biotechnology company, was awarded Phase I and II SBIR grants and contracts that have led to the commercialization of three cancer research tools: MetaMouse®, AngioMouse®, and OncoBrite®.
Awarded more than $4 million to develop a technology platform of safe and effective carriers for therapeutic vaccines based on hemocyanin from the keyhole limpet (KLH) protein.
Join us for I-Corps at NIH info webinar on Dec 8, 2016, 12:30 - 1:30 PM! [REGISTER]
Submit applications for Direct-to-Phase-II pilot programs by Jan 5, 2017!
The 2017 I-Corps at NIH FOA is now available. Next deadline=Nov 1, 2016! [MORE]